Last updated: 2026-10-14 10:43:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Canopy Growth Corporation (CGC) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $0.77, with a market capitalisation of $320.45M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.74 to $2.38. This page covers its latest market performance, valuation, price trends and company information.
$320.45M | |
$0.77 | |
$592.50 | |
$0.74 | |
$0.76 | |
149.00 | |
2.91M | |
-- | |
$2.38 | |
$0.74 | |
-- | |
-- |
Canopy Growth Corporation (CGC) is trading at $0.77 in pre-market trading as of 2026-10-14 09:23:00, up 0.85% ($0.01) from the previous close of $0.76
Pre-market trading shows how investors are pricing CGC before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Canopy Growth Corporation (CGC) moved from $0.88 to $0.77, representing a decline of 13.06% ($0.12).
The stock traded between $0.74 and $0.90 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.87 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.7%
CGC is currently trading at $0.77, placing it 1.7% of the way from its 52-week low of $0.74 to its 52-week high of $2.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 1128 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Canopy Growth Corporation (CGC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.